News

Get our latest updates here!

2020

IN THE NEWS

CARTANA launches expanded range of In Situ Sequencing kits for high throughput single cell gene expression mapping

14 May 2020

CARTANA launches expanded range of  In Situ Sequencing (ISS) kits designed to increase the efficiency and enable ISS on virtually any tissue sample.

Read the article here

2020

PRESS RELEASE

NEXT GENERATION ISS PRODUCTS: High Sensitivity Library Preparation Kit and In Situ Sequencing Kit

1 May 2020

CARTANA launches expanded range of  In Situ Sequencing kits for high throughput single cell gene expression mapping. Universal capability for all organs and species on fresh/fixed frozen & FFPE samples

Read the press release here

2020

IN THE NEWS

New Products Posted to GenomeWeb: Horizon Discovery, Cartana, ProteoGenix, More

1 May 2020

News on CARTANA new products have gotten out! CARTANA new products are being featured on genomeweb!

Read the article here

2020

IN THE NEWS

Biocompare: Probing the Tumor Microenvironment

28 April 2020

How is cancer influenced by its environment, and, just as importantly, how does cancer affect the Tumor microenvironment? CARTANA’s platform, which works on both FFPE and frozen tissue samples can provide the answers to these questions.

Read the article here

2020

IN THE NEWS

Nordic Life Science News: CARTANA’s In Situ Sequencing chosen as key enabling technology in European Horizon 2020 funded projects

29 January 2020

CARTANA has been featured on the Nordic Life Science News and was recognized as the key enabling technology in European Horizon 2020 funded projects. We are delighted to be the partner for half of the European funded HCA projects!

Read the article here

2019

AWARD

Nominated Deep Tech Pioneers

12 November 2019

From over 5000 applications, CARTANA has been nominated as one of the Deep Tech Pioneer and selected as one of the seven ‘Medical Biotech’ finalists!

2019

PODCAST

Podcast at King’s College London

16 October 2019

King’s College London has recently released a podcast with CARTANA. In this podcast, Ph.D. student Dr. Xinyi (Beibei) Du discussed about Single-cell and Spatial Transcriptomics with our CEO and Co-founder, Dr. Malte Kühnemund.

Click here to tune in

2019

APPLICATION NOTES

Application Note: Mapping brain cell types with CARTANA In Situ Sequencing on the Nikon Ti2-E microscope

3 October 2019

CARTANA has recently published an application note “Mapping brain cell types with CARTANA In Situ Sequencing (ISS) on the Nikon Ti2-E microscope” in Nature Methods, October 2019. In this application, we show in details how CARTANA ISS is used for mapping transcriptional cell types within the spatial context of mouse brain sections and we thought this can benefit your research.

Read Application Note here

2019

AWARD

SME Instrument Phase I

4 September 2019

CARTANA was awarded SME Instrument Phase I from Vinnova. The funding will be used for the improvement of the Library Preparation Kit and to adapt it to be used in the application of oncology, especially immuno-oncology, as well as other areas.

Read More

2019

PUBLICATION

“Spatial and temporal transcriptomics reveal microglia-astroglia crosstalk in the amyloid-β plaque cell niche of Alzheimer’s disease”

12 August 2019

Chen W.T., and Craessaerts, K. et al. (BioRxiv, 2019)

In a recent study by Chen et al. on the effect of the amyloid-β plaque formation on Alzheimer’s disease progress, the use of CARTANA’s ISS technology plays a crucial role by providing insight at the single-cell level and making possible to describe induced transcriptional responses of different brain cells with spatial context. For the first time, a more conclusive evidence on the roles of amyloid plaques in the neurodegenerative process was drawn.

Read the Paper in BioRxiv here

2019

PUBLICATION

“Spatio-Temporal Structure of Cell Fate Decisions in Murine Neural Crest”

1 July 2019

Soldatov R, Kaucka M. and Kastriti M.E ( Science, 2019)

In this study of the cell fate decision progress of neural crest cells, In Situ Sequencing by Cartana proved to be a crucial complement to the standard methods of single cell sequencing. For the first time, the molecular logic of cell fate decision involved in these rapidly changing cells was revealed- by the dimensions of time and space.

Read the White Paper here

2019

PRESS RELEASE

CARTANA, Lunaphore and Stockholm University have started a collaboration on automated Next Generation In Situ Sequencing

10 June 2019

The collaboration aims at the integration and automation of CARTANA’s Next Generation In Situ Sequencing (NGISS) on Lunaphore’s microfluidic tissue processor technology that will greatly simplify In Situ Sequencing workflows in laboratories.

Press ReleaseGenomeweb

2018

AWARD

Innovative Start up Phase II Grant

8 October 2018

CARTANA was awarded Innovative Start up Phase II from Vinnova. The funding will be used for the development of the next generation of In Situ Sequencing.

Read More

2018

PRESS RELEASE

CARTANA secures $1M for a tech platform understanding the brain and its diseases

8 October 2018

CARTANA has received $1M funding from a group of private investors via Sciety and Almi Invest. The funding will be used for further development of the product and market launch.

ALMI InvestNORDIC9

2018

PUBLICATION

“A spatial atlas of inhibitory cell types in mouse hippocampus”

1 October 2018

Xiaoyan Qian et al., bioRxiv 431957 (October 1) 2018; doi: https://doi.org/10.1101/431957

The latest publication from the Nilsson lab at Scilifelab and Harris lab at UCL in Biorxiv.
They built a spatial atlas of hippocampal CA1 cell types by In Situ sequencing 99 genes in mouse brain sections and demonstrate a probabilistic cell typing method that converts In Situ sequencing data into spatial cell type maps.

Read the paper here

2018

AWARD

SALSS- Swedish American Life Science Summit

22 August 2018

CARTANA has been selected for SALSS Rising Star Award 2018. This year´s focus is “ALL ABOUT BRAINS”.

Read More

2018

PRESS RELEASE

CARTANA NEURO KIT

01 June 2018

CARTANA is proud to launch its first product, the NeuroKit. CARTANA’s NeuroKit is an optimized reagent kit that enables the mapping of hundreds of genes and cell types via In Situ Sequencing (ISS) in a single tissue section with high throughput and high sensitivity.

The Neuro Kit